|Articles|August 1, 2001
- Pharmaceutical Executive-08-01-2001
- Volume 0
- Issue 0
Generics: Streamline and Stimulate
Author(s)Kevin Gopal
Brussels-Lack of intellectual property protection is not causing the erosion of European pharma, reports the European Generics Association.
Advertisement
Articles in this issue
about 25 years ago
Decision Making at Digital Speedabout 25 years ago
Mergers: Big Pharma Shrinks Someabout 25 years ago
Grace Under Fireabout 25 years ago
Get Ready to Merge or Divergeabout 25 years ago
Pharma's Quantum Shuffleabout 25 years ago
Science-Driven MarketingAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5